Reaction
Encephalitis Cytomegalovirus reporting signals
As of the last recalculation, Encephalitis Cytomegalovirus appears in 427 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR SODIUM (PRR 1,365.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ganciclovir Sodium | 175 | 1,365.1 | 1,388.2 |
| Ganciclovir | 170 | 1,344.6 | 1,367.4 |
| Valganciclovir Hydrochloride Powder, | 115 | 628.6 | 634.6 |
| Valganciclovir | 146 | 573.1 | 577.6 |
| Valganciclovir Hydrochloride | 146 | 573.1 | 577.6 |
| Anti-Thymocyte Globulin (Rabbit) | 66 | 471.5 | 475.4 |
| Fludarabine Phosphate | 145 | 271.7 | 272.7 |
| Busulfan | 42 | 144.2 | 144.6 |
| Thiotepa | 17 | 90.3 | 90.5 |
| Cyclosporine | 125 | 77.0 | 77.1 |
| Budesonide | 70 | 69.1 | 69.2 |
| Cyclophosphamide Injection, Solution | 155 | 66.4 | 66.5 |
| Cyclophosphamide | 155 | 66.4 | 66.5 |
| Cyclophosphamide For Injection | 155 | 66.4 | 66.5 |
| Axicabtagene Ciloleucel | 12 | 61.0 | 61.0 |
| Basiliximab | 13 | 55.5 | 55.6 |
| Rituximab | 141 | 48.0 | 48.1 |
| Bendamustine Hydrochloride | 10 | 41.7 | 41.7 |
| Bendamustine Hcl | 12 | 38.8 | 38.8 |
| Ifosfamide | 16 | 37.7 | 37.7 |
| Melphalan Hydrochloride | 15 | 30.2 | 30.2 |
| Melphalan | 13 | 28.7 | 28.7 |
| Cytarabine | 32 | 28.0 | 28.0 |
| Etoposide | 35 | 25.2 | 25.2 |
| Polatuzumab Vedotin | 4 | 20.2 | 20.2 |
| Obinutuzumab | 6 | 18.0 | 18.0 |